Incannex Healthcare (IXHL) Total Debt (2024 - 2025)

Incannex Healthcare (IXHL) posted quarterly Total Debt of $1.4 million for Q1 2025, down 62.92% on a QoQ basis from $3.8 million in Q4 2024.

Incannex Healthcare (IXHL) Total Debt (2024 - 2025) Analysis & Trends

Incannex Healthcare (IXHL) has reported Total Debt for 2 consecutive years, with $1.4 million the latest figure, recorded in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 11.45 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 16.63 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 28.76 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 7.15 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 14.34 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.81 Bn
10 Incannex Healthcare 3.63 Mn 3.63 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 1.40 Mn
Dec 31, 2024 3.77 Mn